These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26730872)

  • 1. Metabolomics and Mycobacterial Disease: Don't Forget the Bioinformatics.
    Collins JM; Kempker RR; Ziegler TR; Blumberg HM; Jones DP
    Ann Am Thorac Soc; 2016 Jan; 13(1):141-2. PubMed ID: 26730872
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply: Metabolomics and Mycobacterial Disease: Don't Forget the Bioinformatics.
    Mirsaeidi M; Banoei MM; Winston BW; Schraufnagel DE
    Ann Am Thorac Soc; 2016 Jan; 13(1):142-3. PubMed ID: 26730873
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolomics: Applications and Promise in Mycobacterial Disease.
    Mirsaeidi M; Banoei MM; Winston BW; Schraufnagel DE
    Ann Am Thorac Soc; 2015 Sep; 12(9):1278-87. PubMed ID: 26196272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical metabolomics: a pivotal tool for companion diagnostic development and precision medicine.
    Tolstikov V; Akmaev VR; Sarangarajan R; Narain NR; Kiebish MA
    Expert Rev Mol Diagn; 2017 May; 17(5):411-413. PubMed ID: 28317395
    [No Abstract]   [Full Text] [Related]  

  • 5. Challenges in metabolomics-based disease molecular classification: an analytical perspective.
    Gao Y; Liu Q; Xu F
    Bioanalysis; 2017 May; 9(10):771-773. PubMed ID: 28520467
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolomics through the lens of precision cardiovascular medicine.
    Lam SM; Wang Y; Li B; Du J; Shui G
    J Genet Genomics; 2017 Mar; 44(3):127-138. PubMed ID: 28325553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative methods for analyzing big data in precision medicine.
    Gligorijević V; Malod-Dognin N; Pržulj N
    Proteomics; 2016 Mar; 16(5):741-58. PubMed ID: 26677817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The diagnosis and treatment of rapidly growing non-tuberculous mycobacterial keratitis].
    Guan HJ; Cheng ZP; Yin L; Wu YY; Hu N; Zhang JF; Shi HH
    Zhonghua Yan Ke Za Zhi; 2009 Jun; 45(6):503-8. PubMed ID: 19957672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary nontuberculous mycobacterial infections in immunocompetent patients.
    Cook JL
    Clin Lab Sci; 1999; 12(5):302-8. PubMed ID: 10623329
    [No Abstract]   [Full Text] [Related]  

  • 10. Integrating clinical metabolomics-based biomarker discovery and clinical pharmacology to enable precision medicine.
    Kohler I; Hankemeier T; van der Graaf PH; Knibbe CAJ; van Hasselt JGC
    Eur J Pharm Sci; 2017 Nov; 109S():S15-S21. PubMed ID: 28502671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics as a Tool to Understand Pathophysiological Processes.
    Ivanisevic J; Thomas A
    Methods Mol Biol; 2018; 1730():3-28. PubMed ID: 29363062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nontuberculous mycobacterial diseases--difficult to diagnose and difficult to treat].
    Uibu T; Kellomäki L; Järvenpää R; Risto V; Lumio J
    Duodecim; 2005; 121(11):1176-83. PubMed ID: 15999972
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-tuberculous mycobacterial lymphadenitis in children: diagnosis and management.
    Amir J
    Isr Med Assoc J; 2010 Jan; 12(1):49-52. PubMed ID: 20450132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of individuality in drug metabolism by high-throughput metabolomics: The fast line for personalized medicine.
    Trifonova O; Knight RA; Lisitsa A; Melino G; Antonov AV
    Drug Discov Today; 2016 Jan; 21(1):103-110. PubMed ID: 26220091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An infant with ZAP-70 deficiency with disseminated mycobacterial disease.
    Esenboga S; Ayvaz DC; Cetinkaya PG; van der Burg M; Tezcan İ
    J Clin Immunol; 2016 Feb; 36(2):103-6. PubMed ID: 26707786
    [No Abstract]   [Full Text] [Related]  

  • 16. Feline mycobacterial infections.
    Gunn-Moore DA
    Vet J; 2014 Aug; 201(2):230-8. PubMed ID: 24685470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nontuberculous mycobacterial cutaneous infections: an updated review.
    Khan FA; Khakoo R
    Cutis; 2011 Oct; 88(4):194-200. PubMed ID: 22106729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolomics has the potential to improve drug therapy].
    Stage C; Jürgens G; Dalhoff KP; Rasmussen HB
    Ugeskr Laeger; 2014 Mar; 176(6):. PubMed ID: 25096206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenosynovitis.
    Neviaser RJ
    Hand Clin; 1989 Nov; 5(4):525-31. PubMed ID: 2808551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A metabolomics approach to characterise and identify various Mycobacterium species.
    Olivier I; Loots du T
    J Microbiol Methods; 2012 Mar; 88(3):419-26. PubMed ID: 22301369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.